Showing 5,401 - 5,420 results of 60,851 for search '(( 5 ((we decrease) OR (nn decrease)) ) OR ( 50 ((greater decrease) OR (a decrease)) ))', query time: 1.16s Refine Results
  1. 5401
  2. 5402

    Effect of anti-miR-146a LNA or miR-146a mimic upon IL-1β-induced release of inflammatory molecules. by Anand Iyer (135705)

    Published 2012
    “…<p>(<b>A</b>) Cytokine release 24 hours after exposure to IL-1β in U373 cells transfected with LNA-antimiR-146a (50 nM) or miR-146a mimic (miR-146a mimic, 50 nM). …”
  3. 5403

    Decomposition analysis of AYAs with liver cancer. by Mengjia Zhu (15469202)

    Published 2025
    “…Regarding SDI regions, we found that the ASIR of AYAs with CRC increased in all five Social Demographic Index (SDI) regions. …”
  4. 5404
  5. 5405

    Image_5_Genetic Variation in CCL5 Signaling Genes and Triple Negative Breast Cancer: Susceptibility and Prognosis Implications.JPEG by Jingxuan Shan (4711089)

    Published 2019
    “…We found a highly significant association between the CCND1 rs614367-TT genotype (OR = 5.14; P = 0.004) and TNBC risk, and identified a significant association between the rs614367-T allele and decreased PFS in TNBC. …”
  6. 5406

    Table_5_Genetic Variation in CCL5 Signaling Genes and Triple Negative Breast Cancer: Susceptibility and Prognosis Implications.DOCX by Jingxuan Shan (4711089)

    Published 2019
    “…We found a highly significant association between the CCND1 rs614367-TT genotype (OR = 5.14; P = 0.004) and TNBC risk, and identified a significant association between the rs614367-T allele and decreased PFS in TNBC. …”
  7. 5407

    H12 values in sweeps of varying softness. by Nandita R. Garud (694498)

    Published 2015
    “…H12 values rapidly decline as the softness of a sweep increases and as the ending partial frequency of the adaptive allele decreases. In (C) and (D), <i>s</i> was varied while keeping <i>PF</i> constant at 0.5 for sweeps from <i>de novo</i> mutations and SGV, respectively. …”
  8. 5408

    Fig 6 - by Matthew C. Kochem (18476069)

    Published 2024
    “…Plasma glucose, insulin, and glucagon were measured before, during, and after OGTTs up to 120 minutes post-prandially. We also assessed individual participants’ sweet taste responses to sucralose and their sensitivities to lactisole sweetness inhibition. …”
  9. 5409

    Fig 2 - by Matthew C. Kochem (18476069)

    Published 2024
    “…Plasma glucose, insulin, and glucagon were measured before, during, and after OGTTs up to 120 minutes post-prandially. We also assessed individual participants’ sweet taste responses to sucralose and their sensitivities to lactisole sweetness inhibition. …”
  10. 5410

    Fig 1 - by Matthew C. Kochem (18476069)

    Published 2024
    “…Plasma glucose, insulin, and glucagon were measured before, during, and after OGTTs up to 120 minutes post-prandially. We also assessed individual participants’ sweet taste responses to sucralose and their sensitivities to lactisole sweetness inhibition. …”
  11. 5411

    Participant traits. by Matthew C. Kochem (18476069)

    Published 2024
    “…Plasma glucose, insulin, and glucagon were measured before, during, and after OGTTs up to 120 minutes post-prandially. We also assessed individual participants’ sweet taste responses to sucralose and their sensitivities to lactisole sweetness inhibition. …”
  12. 5412

    Fig 4 - by Matthew C. Kochem (18476069)

    Published 2024
    “…Plasma glucose, insulin, and glucagon were measured before, during, and after OGTTs up to 120 minutes post-prandially. We also assessed individual participants’ sweet taste responses to sucralose and their sensitivities to lactisole sweetness inhibition. …”
  13. 5413

    Fig 3 - by Matthew C. Kochem (18476069)

    Published 2024
    “…Plasma glucose, insulin, and glucagon were measured before, during, and after OGTTs up to 120 minutes post-prandially. We also assessed individual participants’ sweet taste responses to sucralose and their sensitivities to lactisole sweetness inhibition. …”
  14. 5414
  15. 5415

    Identification of Adenylate Kinase 5 as a Protein Target of Ginsenosides in Brain Tissues Using Mass Spectrometry-Based Drug Affinity Responsive Target Stability (DARTS) and Cellul... by Feiyan Chen (775268)

    Published 2022
    “…Then, we identified and confirmed adenylate kinase 5 (AK5) as a target protein of ginsenosides by biolayer interferometry (BLI), isothermal titration calorimetry (ITC), and molecular docking. …”
  16. 5416

    Identification of Adenylate Kinase 5 as a Protein Target of Ginsenosides in Brain Tissues Using Mass Spectrometry-Based Drug Affinity Responsive Target Stability (DARTS) and Cellul... by Feiyan Chen (775268)

    Published 2022
    “…Then, we identified and confirmed adenylate kinase 5 (AK5) as a target protein of ginsenosides by biolayer interferometry (BLI), isothermal titration calorimetry (ITC), and molecular docking. …”
  17. 5417
  18. 5418

    The Synergistic Roles of Cholecystokinin B and Dopamine D<sub>5</sub> Receptors on the Regulation of Renal Sodium Excretion by Xiaoliang Jiang (845022)

    Published 2016
    “…Hence, we sought to investigate the interaction between D<sub>5</sub>R and CCK<sub>B</sub>R in the regulation of renal sodium excretion. …”
  19. 5419

    Risk assessment for hospital admission in patients with COPD; a multi-centre UK prospective observational study by Jilles M. Fermont (3746068)

    Published 2020
    “…In total, 291 of 714 individuals experienced 762 hospitalised AECOPD during five-year follow up. Poorer performance of SPPB was associated with both higher rate (IRR 1.08 per 1 point decrease, 95% CI 1.01 to 1.14) and increased length of stay (IRR 1.18 per 1 point decrease, 95% CI 1.10 to 1.27) for hospitalised AECOPD. …”
  20. 5420